Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
SpectraScience Raises $4.3M Bruce V. Bigelow 11/06/09 San Diego
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer Luke Timmerman 11/05/09 Boston
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment Luke Timmerman 11/05/09 Seattle
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News Luke Timmerman 11/05/09 Seattle
Calypso Teams Up with Siemens Gregory T. Huang 11/03/09 Seattle
On-Q-ity Raises $21M in A Round for Personalized Cancer Testing Ryan McBride 11/03/09 Boston
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait Luke Timmerman 11/02/09 Seattle
Virdante Pharma Lands $30M in A Round to Combat Inflammation Ryan McBride 10/29/09 Boston
TEDMED Sessions Seek the Patterns in Health Care and Life Sciences That Hold Ideas Together Bruce V. Bigelow 10/28/09 San Diego
Nuclea Nabs $3.4M Deal Luke Timmerman 10/22/09 Boston
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News Luke Timmerman 10/22/09 Seattle
Antigenics Shares Plummet as Cancer Vaccine Application Rejected in Europe Luke Timmerman 10/21/09 Boston
Augmenix Snags $6.1M Luke Timmerman 10/19/09 Boston
Calistoga Cancer Drug Shows “Encouraging” Preliminary Results in Small Study Luke Timmerman 10/19/09 Seattle
Top 10 Highlights from FiReGlobal: Michael Dell, Lee Hartwell, Irwin Jacobs, and More Gregory T. Huang 10/16/09 Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News Luke Timmerman 10/15/09 Seattle
Five Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney Luke Timmerman 10/15/09 Seattle
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice Bruce V. Bigelow 10/14/09 San Diego
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News Gregory T. Huang 10/14/09 Seattle
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days Luke Timmerman 10/14/09 Seattle
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes Ryan McBride 10/14/09 Boston
Seattle Genetics Adds Marketing Boss Luke Timmerman 10/13/09 Seattle
Dendreon Recruits Genentech CEO, Former Lilly Manufacturing Chief to Board Luke Timmerman 10/09/09 Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent Luke Timmerman 10/09/09 National
Polaris Picks Immuneering, Developer of Personalized Cancer Test, as First Life Sciences Startup in Dog Patch Incubator Luke Timmerman 10/08/09 Boston
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News Luke Timmerman 10/08/09 Seattle
Epizyme Snags $32M Round to Make Drugs Against Cancer and More Luke Timmerman 10/07/09 Boston
Geospiza Wins NIH Cancer Grant Luke Timmerman 10/07/09 Seattle
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles Luke Timmerman 10/06/09 Seattle
Genzyme Drug Fails to Win FDA Nod Luke Timmerman 10/06/09 Boston
Page 1 of 15 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.